Aleksandr Aleksandrovich Bezmenko

Aleksandr Aleksandrovich Bezmenko

Auto-generated profile, based on publicly available information

Aleksandr Aleksandrovich Bezmenko

Kirov Military Medical Academy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2014 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
ABAleksandr Aleksandrovich Bezmenko
Aleksandr Aleksandrovich Bezmenko
ASAndrey Aleksandrovich Shmidt
Andrey Aleksandrovich Shmidt
AKAnna Andreyevna Koval
Anna Andreyevna Koval
SSSergey Aleksandrovich Sibirev
Sergey Aleksandrovich Sibirev
ZKZhanna Mikhaylovna Karpishchenko
Zhanna Mikhaylovna Karpishchenko
DGDmitriy Ivanovich Gayvoronskikh
Dmitriy Ivanovich Gayvoronskikh
The article presents the results of morphological evaluation of the vaginal tissues in women before and after treatment of stress incontinence with Er: YAG-laser (technologies IntimaLase and IncontiLase). Marked histological changes (increase of quantity and activity of fibroblasts, the increase of density of connective tissue, the emergence of neoangiogenesis plots) confirm the clinical efficacy of the method (the positive effect was obtained in 70,7 % of patients with I type of UI and 47 % with the II type of UI light and medium gravity).

30 June 2025 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
BBBezmenko A.A. Bezmenko
Bezmenko A.A. Bezmenko
ZZZakharov I.S. Zakharov
Zakharov I.S. Zakharov
BBBezhenar V.F. Bezhenar
Bezhenar V.F. Bezhenar
SSStaroverova A.S. Staroverova
Staroverova A.S. Staroverova
BBBagramyan E.A. Bagramyan
Bagramyan E.A. Bagramyan
MAMinistry Of Defense Of The Russian Federation S.M. Kirov Military Medical Academy
Ministry Of Defense Of The Russian Federation S.M. Kirov Military Medical Academy

19 May 2024 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
EUElena A. Ulrikh
Elena A. Ulrikh
VBV. G. Borshchevskiy
V. G. Borshchevskiy
IZI. S. Zakharov
I. S. Zakharov
ABA. A. Bezmenko
A. A. Bezmenko
DGD. I. Gayvoronskikh
D. I. Gayvoronskikh
ABA. K. Bairova
A. K. Bairova
Cervical cancer occupies one of the leading places in the structure of oncological diseases of the Female Reproductive System. In the treatment of this pathology, along with the surgical method of treatment, chemotherapy and radiation therapy are used. According to clinical guidelines, in the presence of cervical cancer stages IIB–IIIA, it is allowed to carry out 2–4 cycles of neoadjuvant chemotherapy in order to create conditions for the possibility of performing extended hysterectomy according to Meigs. Pregnancy during chemotherapy is unique and extremely rare.The article presents a clinical case of pregnancy during chemotherapy (performed according to the scheme: taxanes and platinum-containing drugs) in a 27-year-old patient. According to the clinical picture and results of cervical biopsy, the diagnosis was made: invasive nonkeratinizing squamous cell carcinoma of the cervix IIB (cT2bNxM0) G2, right-sided parametric variant, nonspecific (with unspecified HPV status). Taking into account the presence of parametrial infiltration, the age of the patient, the oncological council prescribed from 2 to 4 cycles of chemotherapy according to the TC scheme (paclitaxel, carboplatin) with an interval assessment. After the second cycle of chemotherapy, an early pregnancy was diagnosed – a medical abortion was performed. Against the background of 3 cycles of chemotherapy, the conditions for surgical treatment were formed – surgical treatment was performed in the amount of extended hysterectomy according to Meigs (type III according to Piver/C2 Morrow) with transposition of the ovaries. The postoperative period was uneventful; the patient was discharged in a satisfactory condition.The described case of pregnancy on the background of chemotherapy is of scientific and practical interest, initiating a discussion on the need to counsel such patients regarding reliable contraception, taking into account the eligibility criteria, which will avoid undesirable outcomes during cancer treatment.

22 April 2024 in Russian Military Medical Academy Reports
Verified
Journal Article
Open access
PDF file
NSNataliya D. Sadovaya
Nataliya D. Sadovaya
ABAleksandr A. Bezmenko
Aleksandr A. Bezmenko
The epidemiological situation of cervical cancer is assessed as unsatisfactory in Russia. The morbidity rate is one of the highest in Europe, and morbidity and mortality rates continue to increase. There were 12,201 new cases of cervical malignant lesions, 6,322 women in our country died from this disease, and the mortality rate was 9.6 per 100,000 women in 2021. At the same time, cervical cancer is one of the few nosological forms of malignant neoplasms that can currently be prevented through vaccination. The disease is suitable for population screening for secondary prevention. Large-scale vaccination against human papillomavirus and properly organized population screening have reduced the mortality rate from cervical cancer to 2 cases per 100 thousand women in 2020 in Australia. If the country continues to stay the course, by 2034 the number of fatalities will be less than 1 in 100,000 per year. The article provides an analysis of current approaches to screening and prevention of cervical cancer worldwide to determine a more effective strategy. We anticipate that the collaborative actions of a health care organization, motivated health care providers, and women interested in their health will lead to a positive trend in cervical cancer prevention in our state.

17 May 2026 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Closed access
IZI. S. Zakharov
I. S. Zakharov
ANA. A. Nazarenko
A. A. Nazarenko
ABA. A. Bezmenko
A. A. Bezmenko
OSO. A. Sharshova
O. A. Sharshova
In 2025, it will be 120 years since the first successful full-fledged telemedicine communication. This article describes the main stages of telemedicine development. The first attempts to provide remote medical care are inextricably linked with the invention of the telegraph. Throughout the 20th century and the first quarter of the 21st century, telemedicine technologies have been progressively developing. The authors analyzed the general chronological dynamics of the distribution of scientific publications on telemedicine — a significant increase in publication activity occurred during the COVID-19 pandemic, which became an important stage in the development and transformation of this area of medical services. Using cluster analysis, a classification of areas in which telemedicine is actively used was carried out. Promising areas were identified, one of which is the combination of telemedicine with artificial intelligence. The active development of telemedicine is changing approaches to medical care and forming a new understanding of the relationship «doctor–patient», «doctor–doctor» and «patient–patient».

8 April 2021 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
ABAlexander A. Bezmenko
Alexander A. Bezmenko
NSNatalia D. Sadovaya
Natalia D. Sadovaya
MMMarina E. Meshkova
Marina E. Meshkova
EMElena A. Malakhova
Elena A. Malakhova
СДСадовая Наталья Дмитриевна
Садовая Наталья Дмитриевна
Hypothesis/Aims of study: Systemic endotoxinemia resulting from intestinal dysbiosis activates the Th1 immune response and excessive production of proinflammatory cytokines, which can cause abortion. This study was aimed at assessing interleukin levels in women with the threat of miscarriage and exploring their dependence on intestinal microbiocenosis and the level of endotoxinemia. Study design, materials and methods: The study involved 87 women aged 18 to 43 years in pregnancy from six to 22 weeks. The main group consisted of 50 women with a threatened miscarriage. The control group included 37 women with normal pregnancy. A qualitative and quantitative analysis of intestinal microbiocenosis was performed by real-time PCR, with endotoxin and interleukin levels evaluated using conventional methods. Results: In patients of the main group, intestinal dysbiosis of grade I was detected in 30 % (n = 15), of grade II in 46 % (n = 23), and of grade III in 24 % (n = 12) of cases. In the control group, intestinal microflora disorders corresponded to grade I dysbiosis in 67.6 % (n = 25) and grade II dysbiosis in 32.4 % (n = 12) of cases, there being no cases of severe dysbiosis revealed. The level of endotoxin in pregnant women of the main group was 0.57 0.02 nmol / ml and was classified as increased. The endotoxin level in the blood serum of pregnant women of the control group was 0.34 0.02 nmol / ml and was characterized as low (p 0.001). A strong correlation was found (r = 0.8, p 0.001) between the grade of intestinal dysbiosis and the level of endotoxinemia. The cytokine profile in patients of the main group was characterized by increased concentrations of pro-inflammatory cytokines (IL-1 4.9 1.6 pg / ml, IL-6 4.8 1.5 pg / ml) and a decreased concentration of anti-inflammatory cytokine (IL-10 18.0 4.5 pg / ml), when compared to the control group (IL-1 1.8 0.2 pg / ml, IL-6 2.1 0.2 pg / ml, IL-10 30.3 4.4 pg/ml). There were a statistically significant moderate positive correlation between the level of endotoxinemia and the concentration of pro-inflammatory cytokines and a weak negative correlation between the endotoxin level and the concentration of anti-inflammatory IL-10. Conclusion: Endotoxinemia, which occurs as a result of intestinal microflora dysbiosis and activates pro-inflammatory pathways, can really be as a triggering factor in the pathogenesis of miscarriage in pregnant women.